The IL-10R1 S138G loss-of-function allele and ulcerative colitis

被引:27
作者
Grundtner, P.
Gruber, S.
Murray, S. S. [2 ]
Vermeire, S. [3 ]
Rutgeerts, P. [3 ]
Decker, T. [4 ]
Lakatos, P. L. [5 ]
Gasche, C. [1 ,6 ]
机构
[1] Med Univ Vienna, Div Gastroenterol & Hepatol, AKH KIM 3, Dept Med 3, A-1090 Vienna, Austria
[2] Scripps Genom Med, La Jolla, CA USA
[3] Univ Hosp Gasthuisberg, Dept Gastroenterol, B-3000 Louvain, Belgium
[4] Univ Vienna, Max F Perutz Labs, Vienna, Austria
[5] Semmelweis Univ, Dept Med 1, H-1085 Budapest, Hungary
[6] Christian Doppler Lab Mol Canc Chemoprevent, Vienna, Austria
基金
奥地利科学基金会;
关键词
inflammatory bowel disease; ulcerative colitis; interleukin-10; receptor; single-nucleotide polymorphism; STAT; INFLAMMATORY-BOWEL-DISEASE; RECOMBINANT HUMAN INTERLEUKIN-10; GENOME-WIDE ASSOCIATION; ACTIVE CROHNS-DISEASE; CHRONIC ENTEROCOLITIS; T-CELLS; RECEPTORS; GENE; MICE; SUSCEPTIBILITY;
D O I
10.1038/gene.2008.72
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Genetic predisposition is a risk factor for the development of inflammatory bowel diseases (IBDs). Disruption of the interleukin (IL)-10 pathway in mice causes intestinal inflammation similar to human IBD. Two common non-synonymous IL-10R1 variants, S138G and G330R, were cloned and expressed in HeLa and Ba/F3. A reduction in IL-10-induced STAT1 and STAT3 activation was seen for IL-10R1-S138G (but not IL-10R1-G330R) by phosphospecific western blotting in both cell types. When analyzing 52 world populations for the presence of IL-10R1 variants, a strong dissimilarity was found between major geographical regions. In addition, when 182 IBD-parent trios were genotyped for both variants, a reduced transmission of haplotype -7 (carrying the S138G variant allele) to offspring with ulcerative colitis (UC) was observed. This UC-protective effect of S138G was confirmed in a Hungarian cohort (n=185, allele frequency 11.6 versus 17.5%; P=0.017) but not in an independent Belgian cohort (n=666, allele frequency 15.9 versus 15.5%; P=0.8). In conclusion, the IL-10R1 S138G variant is a loss-of-function allele for IL-10-induced STAT1 and STAT3 activation but does not protect from UC susceptibility.
引用
收藏
页码:84 / 92
页数:9
相关论文
共 33 条
[1]   In situ expression of interleukin-10 in noninflamed human gut and in inflammatory bowel disease [J].
Autschbach, F ;
Braunstein, J ;
Helmke, B ;
Zuna, I ;
Schürmann, G ;
Niemir, ZI ;
Wallich, R ;
Otto, HF ;
Meuer, SC .
AMERICAN JOURNAL OF PATHOLOGY, 1998, 153 (01) :121-130
[2]   Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease [J].
Barrett, Jeffrey C. ;
Hansoul, Sarah ;
Nicolae, Dan L. ;
Cho, Judy H. ;
Duerr, Richard H. ;
Rioux, John D. ;
Brant, Steven R. ;
Silverberg, Mark S. ;
Taylor, Kent D. ;
Barmada, M. Michael ;
Bitton, Alain ;
Dassopoulos, Themistocles ;
Datta, Lisa Wu ;
Green, Todd ;
Griffiths, Anne M. ;
Kistner, Emily O. ;
Murtha, Michael T. ;
Regueiro, Miguel D. ;
Rotter, Jerome I. ;
Schumm, L. Philip ;
Steinhart, A. Hillary ;
Targan, Stephan R. ;
Xavier, Ramnik J. ;
Libioulle, Cecile ;
Sandor, Cynthia ;
Lathrop, Mark ;
Belaiche, Jacques ;
Dewit, Olivier ;
Gut, Ivo ;
Heath, Simon ;
Laukens, Debby ;
Mni, Myriam ;
Rutgeerts, Paul ;
Van Gossum, Andre ;
Zelenika, Diana ;
Franchimont, Denis ;
Hugot, Jean-Pierre ;
de Vos, Martine ;
Vermeire, Severine ;
Louis, Edouard ;
Cardon, Lon R. ;
Anderson, Carl A. ;
Drummond, Hazel ;
Nimmo, Elaine ;
Ahmad, Tariq ;
Prescott, Natalie J. ;
Onnie, Clive M. ;
Fisher, Sheila A. ;
Marchini, Jonathan ;
Ghori, Jilur .
NATURE GENETICS, 2008, 40 (08) :955-962
[3]   A phase I trial with Transgenic bacteria expressing interleukin-10 in Crohn's disease [J].
Braat, Henri ;
Rottiers, Pieter ;
Hommes, Daniel W. ;
Huyghebaert, Nathalie ;
Remaut, Erik ;
Remon, Jean-Paul ;
Van Deventer, Sander J. H. ;
Neirynck, Sabine ;
Peppelenbosch, Maikel P. ;
Steidler, Lothar .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2006, 4 (06) :754-759
[4]  
Cann HM, 2002, SCIENCE, V296, P261
[5]   The application of molecular genetic approaches to the study of human evolution [J].
Cavalli-Sforza, LL ;
Feldman, MW .
NATURE GENETICS, 2003, 33 :266-275
[6]   STATs and gene regulation [J].
Darnell, JE .
SCIENCE, 1997, 277 (5332) :1630-1635
[7]   The interleukin-10 signal transduction pathway and regulation of gene expression in mononuclear phagocytes [J].
Donnelly, RP ;
Dickensheets, H ;
Finbloom, DS .
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 1999, 19 (06) :563-573
[8]   A genome-wide association study identifies IL23R as an inflammatory bowel disease gene [J].
Duerr, Richard H. ;
Taylor, Kent D. ;
Brant, Steven R. ;
Rioux, John D. ;
Silverberg, Mark S. ;
Daly, Mark J. ;
Steinhart, A. Hillary ;
Abraham, Clara ;
Regueiro, Miguel ;
Griffiths, Anne ;
Dassopoulos, Themistocles ;
Bitton, Alain ;
Yang, Huiying ;
Targan, Stephan ;
Datta, Lisa Wu ;
Kistner, Emily O. ;
Schumm, L. Philip ;
Lee, Annette T. ;
Gregersen, Peter K. ;
Barmada, M. Michael ;
Rotter, Jerome I. ;
Nicolae, Dan L. ;
Cho, Judy H. .
SCIENCE, 2006, 314 (5804) :1461-1463
[9]   Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease [J].
Fedorak, RN ;
Gangl, A ;
Elson, CO ;
Rutgeerts, P ;
Schreiber, S ;
Wild, G ;
Hanauer, SB ;
Kilian, A ;
Cohard, M ;
LeBeaut, A ;
Feagan, B .
GASTROENTEROLOGY, 2000, 119 (06) :1473-1482
[10]  
FINBLOOM DS, 1995, J IMMUNOL, V155, P1079